Aliso Viejo-based drug developer Avanir Pharmaceuticals is trying to stop the bleeding. The company, whose stock is down some 90% in the past year, last week said it plans to restructure itself to ...
Avanir has faced intense scrutiny over its marketing of neurological treatment Nuedexta, and now the company is nearing a deal with the Department of Justice to resolve the government's probe. The ...
Avanir Pharmaceuticals, Inc. 's ( AVNR) shares jumped 12.8% on a buyout offer from Japan-based Otsuka Pharmaceutical Co., Ltd. The companies have signed a definitive agreement under which Otsuka will ...
Just to repeat myself – pharmaceutical and medical device firms face extraordinary risks of enforcement under the False Claims Act. While everyone likes to write and focus on FCPA or anti-corruption ...
The Aliso Viejo, California-based company, which makes a drug to control symptoms of Alzheimer’s disease, this week agreed to sell itself to Japan’s Otsuka Holdings Co. for $3.2 billion, or $17 a ...
Aliso Viejo-based Avanir Pharmaceuticals Inc. last week reached out to one member of Big Pharma to diversify and another to settle a legal dispute. The company signed a deal with Whitehouse Station, N ...
Avanir Pharmaceuticals is cutting 73 employees in “sales-related positions,” or roughly 11 percent of its workforce, according to a recent filing with California state officials. A spokesman confirmed ...
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine --Migraine Sufferers ...
AVANIR Pharmaceuticals Says Drug Shows Positive Results; Shares Soar ALISO VIEJO, Calif. -- Avanir Pharmaceuticals today announced positive top-line results from the company's Phase III clinical trial ...
Avanir Pharmaceuticals will lay off 73 U.S. employees, or about 11 percent of its workforce, by the end of January as part of a sales restructuring plan, according to the Orange County Business ...
BANGALORE, Nov 1 (Reuters) - Shares of Avanir Pharmaceuticals Inc more than doubled in value Monday after U.S. regulators approved its treatment for a neurological disorder Friday, making it ...
Avanir Pharmaceuticals is taking its marketing to the next level. It's retiring the pseudobulbar affect (PBA) disease awareness ad it sponsored starring actor Danny Glover, and it's launched its first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results